197 related articles for article (PubMed ID: 27153943)
1. Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Korkmaz-Icöz S; Al Said S; Radovits T; Li S; Brune M; Hegedűs P; Atmanli A; Ruppert M; Brlecic P; Lehmann LH; Lahrmann B; Grabe N; Yoshikawa Y; Yasui H; Most P; Karck M; Szabó G
Cardiovasc Diabetol; 2016 May; 15():75. PubMed ID: 27153943
[TBL] [Abstract][Full Text] [Related]
2. Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction.
Korkmaz S; Atmanli A; Li S; Radovits T; Hegedűs P; Barnucz E; Hirschberg K; Loganathan S; Yoshikawa Y; Yasui H; Karck M; Szabó G
Exp Biol Med (Maywood); 2015 Sep; 240(9):1247-55. PubMed ID: 25670850
[TBL] [Abstract][Full Text] [Related]
3. New Benzofuran
Costa GC; Montagnoli TL; Da Silva JS; de Alencar AKN; Reina Gamba LE; Alves BEO; da Silva MMC; Trachez MM; do Nascimento JHM; Pimentel-Coelho PM; Mendez-Otero R; Lima LM; Barreiro EJ; Sudo RT; Zapata-Sudo G
Drug Des Devel Ther; 2020; 14():3337-3350. PubMed ID: 32884238
[TBL] [Abstract][Full Text] [Related]
4. Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.
van den Brom CE; Bosmans JW; Vlasblom R; Handoko LM; Huisman MC; Lubberink M; Molthoff CF; Lammertsma AA; Ouwens MD; Diamant M; Boer C
Cardiovasc Diabetol; 2010 Jun; 9():25. PubMed ID: 20550678
[TBL] [Abstract][Full Text] [Related]
5. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
[TBL] [Abstract][Full Text] [Related]
6. Administration of zinc complex of acetylsalicylic acid after the onset of myocardial injury protects the heart by upregulation of antioxidant enzymes.
Korkmaz-Icöz S; Atmanli A; Radovits T; Li S; Hegedüs P; Ruppert M; Brlecic P; Yoshikawa Y; Yasui H; Karck M; Szabó G
J Physiol Sci; 2016 Mar; 66(2):113-25. PubMed ID: 26497333
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.
Youssef ME; Abdelrazek HM; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2021 Jan; 394(1):11-31. PubMed ID: 32776158
[TBL] [Abstract][Full Text] [Related]
8. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
9. Increased myocardial SERCA expression in early type 2 diabetes mellitus is insulin dependent: In vivo and in vitro data.
Fredersdorf S; Thumann C; Zimmermann WH; Vetter R; Graf T; Luchner A; Riegger GA; Schunkert H; Eschenhagen T; Weil J
Cardiovasc Diabetol; 2012 May; 11():57. PubMed ID: 22621761
[TBL] [Abstract][Full Text] [Related]
10. Activation of retinoid receptor-mediated signaling ameliorates diabetes-induced cardiac dysfunction in Zucker diabetic rats.
Guleria RS; Singh AB; Nizamutdinova IT; Souslova T; Mohammad AA; Kendall JA; Baker KM; Pan J
J Mol Cell Cardiol; 2013 Apr; 57():106-18. PubMed ID: 23395853
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant activity of melatonin in diabetes in relation to the regulation and levels of plasma Cu, Zn, Fe, Mn, and Se in Zucker diabetic fatty rats.
Navarro-Alarcon M; Ruiz-Ojeda FJ; Blanca-Herrera RM; Agil A
Nutrition; 2013 May; 29(5):785-9. PubMed ID: 23352467
[TBL] [Abstract][Full Text] [Related]
12. Alterations in glutathione redox metabolism, oxidative stress, and mitochondrial function in the left ventricle of elderly Zucker diabetic fatty rat heart.
Raza H; John A; Howarth FC
Int J Mol Sci; 2012 Nov; 13(12):16241-54. PubMed ID: 23203193
[TBL] [Abstract][Full Text] [Related]
13. Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway.
Ren M; Pan D; Zha D; Shan Z
Biomed Res Int; 2022; 2022():9687345. PubMed ID: 35928916
[TBL] [Abstract][Full Text] [Related]
14. Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography.
van den Brom CE; Huisman MC; Vlasblom R; Boontje NM; Duijst S; Lubberink M; Molthoff CF; Lammertsma AA; van der Velden J; Boer C; Ouwens DM; Diamant M
Cardiovasc Diabetol; 2009 Jul; 8():39. PubMed ID: 19624828
[TBL] [Abstract][Full Text] [Related]
15. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
16. Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes.
Ramírez E; Klett-Mingo M; Ares-Carrasco S; Picatoste B; Ferrarini A; Rupérez FJ; Caro-Vadillo A; Barbas C; Egido J; Tuñón J; Lorenzo Ó
Cardiovasc Diabetol; 2013 Nov; 12():172. PubMed ID: 24261558
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model.
Wu B; Huang XY; Li L; Fan XH; Li PC; Huang CQ; Xiao J; Gui R; Wang S
J Cell Mol Med; 2019 Nov; 23(11):7651-7663. PubMed ID: 31565849
[TBL] [Abstract][Full Text] [Related]
18. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
19. Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways.
Cai L; Tan Y; Watson S; Wintergerst K
Toxicol Appl Pharmacol; 2023 Oct; 477():116694. PubMed ID: 37739320
[TBL] [Abstract][Full Text] [Related]
20. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
Wasan KM; Risovic V; Yuen VG; McNeill JH
J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
